Shares of Tristel plc (LON:TSTL - Get Free Report) hit a new 52-week high during trading on Friday . The company traded as high as GBX 572.50 ($7.43) and last traded at GBX 372.50 ($4.84), with a volume of 149584 shares trading hands. The stock had previously closed at GBX 385 ($5.00).
Tristel Stock Performance
The company has a 50-day moving average of GBX 417.87 and a 200-day moving average of GBX 443.32. The company has a market cap of £176.31 million, a PE ratio of 2,846.15 and a beta of 0.23. The company has a quick ratio of 3.83, a current ratio of 4.92 and a debt-to-equity ratio of 19.12.
Tristel Increases Dividend
The firm also recently announced a dividend, which will be paid on Friday, December 20th. Stockholders of record on Thursday, November 28th will be paid a GBX 8.28 ($0.11) dividend. This represents a dividend yield of 2.1%. The ex-dividend date is Thursday, November 28th. This is an increase from Tristel's previous dividend of $5.24. Tristel's payout ratio is presently 10,000.00%.
Insider Buying and Selling
In related news, insider Elizabeth Dixon sold 50,000 shares of the business's stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of GBX 397 ($5.15), for a total value of £198,500 ($257,725.27). 4.89% of the stock is currently owned by corporate insiders.
Tristel Company Profile
(
Get Free Report)
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
See Also
Before you consider Tristel, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tristel wasn't on the list.
While Tristel currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
